Abstract:
Sulfonylureas (I; R1 =H C1-6 alkyl, OR C3-8 cycloalkyl; R2= C1-6 alkyl C3-8 cycloalkyl ,or R1 and R2are forming heterocyclic compd. with nitrogen which is attached in R1 or R2 ; R3 = e.g., C1-8 alkyl C3-8 alkenyl-alkyl, or C5-8 cycloalkyl, or c7-10 endoalkylene-cycloalkyl), useful as antidiabetics, were prepd. by treating sulfonyl isocyanate (II) or sulfonylcarbamic acid derivs. (III; Z = halogen, alkoxy, aryloxy, alkylthio, amino, arylamino, l-imidazolyl, or trichloromethyl) with R3NH2
Abstract:
Title compds. (I;R1 =H or C1-6 alkyl or C3-8 cycloalkyl group R2 = C1-6 alkyl or C3-8 cycloalkyl group, R1 ,R2 can form hetero cyclic rings with N, R3 = C1-8 alkyl, C3-8 alkenyl-alkyl or C5-8 cycloalkyl group ,Z =halogen ,alkoxy, aryloxy, or trichloromethyl group), useful as antidiabetics, were prepd. treating the sulfonamide[II with azide as R3NCO (or R3CON3) or carbamic acid deriv. of R3NHCOZ. Thus I (R1 = R2 =me, R3 = cyclohexyl) at 1μmole/kg orally in dogs decreased the plasma glucose level to 69% of controls in2hr
WHEREIN: R1 IS A MEMBER SELECTED FROM THE GROUP CONSISTING OF HYDROGEN, LOWER ALKYL, LOWER ALKOXY, AND LOWER ALKYLTHIO; R2 IS A MEMBER SELECTED FROM THE GROUP CONSISTING OF HYDROGEN, LOWER ALKYL, LOWER ALKOXY, AND LOWER ALKYLTHIO; R6 IS A MEMBER SELECTED FROM THE GROUP CONSISTING OF HYDROGEN, LOWER ALKYL, LOWER ALKYLTHIO, LOWER AKLANOYLTHIO, AND HALO; R7 IS A MEMBER SELECTED FROM THE GROUP CONSISTING OF HYDROGEN, LOWER ALKYL, LOWER ALKYLTHIO, LOWER ALKANOYLTHIO, AND HALO; R11 IS A MEMBER SELECTED FROM THE GROUP CONSISTING OF HYDROGEN, HYDROXY AND LOWER ALKANOYLOXY; R16 IS A MEMBER SELECTED FROM THE GROUP CONSISTING OF HYDROGEN, LOWER ALKYL, HYDROXY, LOWER ALKOXY, LOWER ALKANOYLOXY, AND, WHEN THE 17B-SUBSTITUENT IS ACETYL OR SUBSTITUTED ACETYL, FLUORINE; Z IS A MEMBER SELECTED FROM THE GROUP CONSISTING OF CARBONYL, (17B-HYDROXY-17-A-LOWER ALKANOIC ACID LACTONE), AND
>C(-R17ALPHA)-R17BETA
R17B IS A MEMBER SELECTED FROM THE GROUP CONSISTING OF HYDROXY, LOWER ALKANOYLOXY, AND
Y-CH2-CO-
Y IS A MEMBER SELECTED FROM THE GROUP CONSISTING OF HYDROGEN, HALO, AND HYDROXY; R17A, WHEN R17B IS HYDROXY AND LOWER ALKANOYLOXY, IS A MEMBER SELECTED FROM THE GROUP CONSISTING OF HYDROGEN AND LOWER ALIPHATIC HYDROCARBYL, AND WHEN R17B IS
Y-CH2-CO-
IS A MEMBER SELECTED FROM THE GROUP CONSISTING OF HYDROGEN ALKYL, HYDROXY, LOWER ALKANOYLOXY, AND HALO; Q WHEN TAKEN ALONE, IS OXO; T1 WHEN TAKEN ALONE, IS A MEMBER SELECTED FROM THE GROUP CONSISTING OF ALKALI METAL OXY AND LOWER ALKOXY; AND T1 AND Q, WHEN TAKEN TOGETHER ARE NITROLO.
Abstract:
PHENETHYLAMIDE DERIVATIVES WHICH ARE N-SUBSTITUTED WITH T-ALKOXYCARBONYL, 5-OXO-2-PYRROLIDINE CARBONYL, PHENYLSULFONYL OR NITROPHENYLTHIO AND ARE USEFUL AS HYPOTENSIVE, ANTIPYRETIC AND ANTI-PARKINSON AGENTS.
Abstract:
Phenylalanine derivatives which are N-substituted with a carbonyl, thio, or sulfonyl substituent useful as hypotensive, anti-pyretic and anti-parkinson agents and processes for their preparation from phenylalanine including intermediates in these processes.
Abstract:
A PROCESS FOR ISOLATING DOPA IN SUBSTANTIALLY PURE FORM FROM AN AQUEOUS MEDIUM CONTAINING WATER INSOLUBLE IMPURITIES BY FORMING A COMPLEX OF L-DOPA WITH A BORIC ACID OR BORATES SALT.
Abstract:
N-CARBONYL, THIO OR SULFONYL SUBSTITUTED CYCLODOPA DERIVATIVES WHICH ARE USEFUL AS HYPOTENSIVE, ANTI-PYRETIC AND ANTI-PARKINSON AGENTS, AND A METHOD OF PREPARING THESE CYCLODPOA DERIVATIVES INCLUDING INTERMEDIATES.
Abstract:
INDOLINE DERIVATIVES SUBSTITUTED IN THE 1-POSITION WITH HYDROGEN, ALKANOYL, BENZOYL, ALKOXY-CARBONYL OR O-NITROPHENYLTHIO, IN THE 2-POSITION WITH A CARBOXY OR ESTER GROUP AND THE 5- AND 6-POSITIONS WITH AN ALKANOYLOXY OR ALKOXY GROUP, WHICH ARE USEFUL AS HYPOTENSIVE, ANTIPYRETIC AND ANTI-PARKINSON AGENTS.